IHT Wealth Management’s Quest Diagnostics DGX Stock Holding History

IHT Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472K	Sell	2,226 -277	-11%	-$54.4K	0.01%	850
2026 Q1	$491K	Buy	2,503 +22	+0.9%	+$4.27K	0.01%	838
2025 Q4	$431K	Buy	2,481 +1,267	+104%	+$231K	0.01%	830
2025 Q3	$231K	Sell	1,214 -30	-2%	-$5.32K	0.01%	1060
2025 Q2	$223K	Buy	+1,244	New	+$216K	0.01%	1037
2018 Q2	–	Sell	-294	Closed	-$29K	–	641
2018 Q1	$29K	Sell	294 -99	-25%	-$10.1K	0.01%	852
2017 Q4	$39K	Buy	393 +2	+0.5%	+$190	0.01%	767
2017 Q3	$36K	Buy	391 +271	+226%	+$28.8K	0.02%	609
2017 Q2	$3	Sell	120 -68	-36%	-$7.19K	﹤0.01%	1166
2017 Q1	$18K	Sell	188 -112	-37%	-$10.7K	0.01%	685
2016 Q4	$28K	Buy	+300	New	+$25.9K	0.02%	529

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

IHT Wealth Management's DGX Position: Q2 2026 in Review

IHT Wealth Management reduced its Quest Diagnostics (DGX) stake by 11% in Q2 2026, selling an estimated $54.4K and leaving 2,226 shares worth $472K. The position accounts for 0.01% of the portfolio, ranked #850.

IHT Wealth Management first reported a position in DGX in Q4 2016 and has held it in 11 quarters since. The position peaked at $491K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

IHT Wealth Management held 2,226 shares of Quest Diagnostics worth $472K as of Q2 2026.
IHT Wealth Management sold 277 Quest Diagnostics shares in Q2 2026, an estimated $54.4K.
Quest Diagnostics made up 0.01% of IHT Wealth Management's portfolio in Q2 2026, its #850 holding.
IHT Wealth Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 11 quarters since.
IHT Wealth Management's Quest Diagnostics position peaked at $491K in Q1 2026.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.